Back

GLP-1 receptor agonists outperform SGLT2 inhibitors in cardiorenal protection following acute myocardial infarction treated with PCI: a large-scale propensity score-matched real-world analysis

30 August 2026 (12:15 - 12:45)
Organised by: Logo
Congress Presentation Part of: Innovations in post-infarction care: cardiometabolic, molecular, and haemodynamic approaches Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Iffat Zahan

Harefield Hospital, Harefield (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Beta blockers and renin-angiotensin-aldosterone system inhibitors after type 2 myocardial infarction, a target trial emulation study
Doctor A. Gard (Uppsala, SE)
Abstract
Presentation thumbnail
Hemodynamic impact of low-dose dobutamine in patients with acute myocardial infarction at risk of cardiogenic shock – a randomized clinical trial
Doctor S. Holle (Copenhagen, DK)
Abstract
Presentation thumbnail
Comparison of oxidative and tissue stress biomarkers and platelet activation in myocardial infarction treated with prasugrel or ticagrelor
Doctor T. Vichova (Prague, CZ)
Abstract
Presentation thumbnail
Sodium-glucose cotransporter 2 inhibitor enhances mitochondrial stress resistance without altering ATP production in patients with ST-elevation myocardial infarction
Miss N. Apaijai (Chiang Mai, TH)
Abstract

Access the full session

Session thumbnail
Innovations in post-infarction care: cardiometabolic, molecular, and haemodynamic approaches

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of early initiation of SGLT2 inhibitor on cardiovascular outcomes in diabetic patients with known atherosclerotic cardiovascular disease or risk factors: propensity score matched analysis
27 August 2021
thumbnail
Congress Presentation
Efficacy and safety of GLP-1 agonists in obesity-related heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized placebo-controlled trials.
1 September 2025
thumbnail
Congress Presentation
Two-year clinical outcomes between statin with ACE inhibitor or ARB in patients with ST-segment elevation myocardial infarction after successful PCI with DES
31 August 2019
thumbnail
Congress Presentation
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction: data from SGLT2-I AMI PROTECT Registry
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources